Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL – Get Free Report) was the recipient of a large growth in short interest in the month of December. As of December 31st, there was short interest totaling 321,082 shares, a growth of 6,821.4% from the December 15th total of 4,639 shares. Based on an average daily trading volume, of 2,087,927 shares, the short-interest ratio is currently 0.2 days. Approximately 0.9% of the company’s stock are short sold. Approximately 0.9% of the company’s stock are short sold. Based on an average daily trading volume, of 2,087,927 shares, the short-interest ratio is currently 0.2 days.
Adlai Nortye Stock Performance
Shares of ANL stock traded down $0.05 during trading hours on Monday, hitting $1.55. 78,647 shares of the company were exchanged, compared to its average volume of 98,921. Adlai Nortye has a one year low of $0.88 and a one year high of $2.75. The business’s 50-day simple moving average is $1.45 and its two-hundred day simple moving average is $1.57.
Analyst Ratings Changes
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Adlai Nortye in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Reduce”.
About Adlai Nortye
Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.
Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.
The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.
Featured Stories
- Five stocks we like better than Adlai Nortye
- A month before the crash
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Trump’s Hand-Written Letter Will Shock his Haters
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- End of America update
Receive News & Ratings for Adlai Nortye Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adlai Nortye and related companies with MarketBeat.com's FREE daily email newsletter.
